Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ENROLLING BY INVITATION
NCT07771283
NA

Purpose to Evaluate the Effectiveness of the Superovulation Stimulation Protocol Using Human Chorionic Gonadotropin (hCG) by Demonstrating Its Equivalence to Standard Controlled Ovarian Stimulation Protocols in Terms of Oocytes Retrieved, Blastulation While Maintaining an Economic Advantage

Sponsor: LTD "EKODNIPRO", Medical centre Medical Plaza Dnipro

View on ClinicalTrials.gov

Summary

This study evaluates a more affordable medication protocol for ovarian stimulation during in vitro fertilization (IVF). Standard IVF protocols use medications called gonadotropins to stimulate the ovaries to produce multiple eggs, but these medications can be very expensive and create a barrier to treatment. This clinical trial tests whether substituting a significant portion of these standard medications with human chorionic gonadotropin (hCG) is just as effective. Researchers will compare the number and quality of eggs and embryos produced by women using the experimental hCG protocol versus those using the standard gonadotropin protocol. The main goal is to determine if the hCG method can provide similar clinical outcomes and safety profiles while significantly reducing the overall financial cost of IVF treatment.

Official title: Prospective Randomized Single-Blind Study of the Effectiveness of the Superovulation Stimulation Protocol Using hCG Compared to Standard Protocols With Different Gonadotropin Doses in In Vitro Fertilization Programs

Key Details

Gender

FEMALE

Age Range

18 Years - 40 Years

Study Type

INTERVENTIONAL

Enrollment

360

Start Date

2026-08-17

Completion Date

2028-05-01

Last Updated

2026-08-27

Healthy Volunteers

No

Interventions

DRUG

Human Chorionic Gonadotropin (hCG)

Administered in sub-trigger doses of 200 IU (without FSH) as a substitute for LH activity and to support folliculogenesis

DRUG

GnRH antagonist

Administered starting on the 6th day of stimulation as part of a fixed antagonist protocol

DRUG

Dual trigger (human chorionic gonadotropin plus GnRH-agonist)

Administered to induce final oocyte maturation before retrieval

DRUG

Gonadotropins (FSH or FSH/LH)

Standard follicle-stimulating hormone (FSH) or FSH/LH preparations administered continuously at doses ranging from 100 to 225 IU/day.

DRUG

Gonadotropins (FSH or FSH/LH)

Standard follicle-stimulating hormone (FSH) or FSH/LH preparations administered continuously at doses ranging from 100 to 225 IU/day before main cohort of follicles reach size 11-12mm

Locations (3)

Sali international school of fertility medicine

Kampala, Uganda

LTD "Yuzko" Yuzko Medical Center

Chernivtsi, Ukraine

LTD "EKODNIPRO" Medical Centre "Medical Plaza"

Dnipro, Ukraine